<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="are credited.https://www.excli.de/vol19/Rangel_17032020_proof.pdf Abstract Direct-acting antivirals are effective tools to control" exact="viral" post="infections. SARS-CoV-2 is a coronavirus associated with the epidemiological"/>
 <result pre="HIV Introduction At present there is not specific treatment for" exact="coronavirus infection." post="However, prior outbreaks have helped to decipher the main"/>
 <result pre="those described for Influenza viruses (Menachery et al., 2017[7]). Thus," exact="viral" post="replication will produce a diverse population of genome variants"/>
 <result pre="efforts toward discovering efficient drugs to prevent and treat SARS-CoV-2" exact="infection" post="should include the prior structural and pharmacological knowledge gained"/>
 <result pre="a treatment against SARS-CoV-2 infections. Materials and Methods Sequence analysis" exact="Protein" post="sequences of the main protease were individually retrieved from"/>
 <result pre="molecules and all crystallographic water molecules. Hydrogens were added and" exact="partial" post="charges were assigned to all atoms. The obtained PDB"/>
 <result pre="of SARS-CoV-2 protease producing an interaction with a binding energy" exact="lower" post="than -6.9 Kcal/mol. However, the compound that produced the"/>
 <result pre="affecting more than 70 countries, therapeutic alternatives are urgently required." exact="Viral" post="main protease plays a pivotal role in coronavirus replication."/>
 <result pre="inhibitory effects over proteases from pathogens such as Leishmania and" exact="malaria" post="(Valdivieso et al., 2010[16]; Sonoiki et al., 2016[15]; de"/>
 <result pre="al., 2014[1]). Thus, the use of protease inhibitors in other" exact="viral" post="species could be supported by these non-specific protease inhibitions."/>
 <result pre="patients infected with SARS-CoV-2 and treated with lopinavir could achieve" exact="viral" post="clearance (Lim et al., 2020[6]). Our study suggests that"/>
 <result pre="be used as therapy and/or pre-exposure prophylaxis to reduce new" exact="infections" post="by SARS-CoV-2. Additionally, the data obtained from prior outbreaks,"/>
 <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell cultureAntimicrob Agents Chemother2014584875–8424841269 2de"/>
 <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother2014584875–8424841269 2de WitEFeldmannFCroninJJordanROkumuraAThomasTet"/>
 <result pre="Med Chem Lett2003133989399214592491 4KhalidMAl RabiahFKhanBAl MobeireekAButtTSAl MutairyERibavirin and interferon-α2b as" exact="primary" post="and preventive treatment for Middle East respiratory syndrome coronavirus:"/>
 <result pre="and interferon-α2b as primary and preventive treatment for Middle East" exact="respiratory" post="syndrome coronavirus: a preliminary report of two casesAntivir Ther20152087–9124831606"/>
 <result pre="interferon-α2b as primary and preventive treatment for Middle East respiratory" exact="syndrome" post="coronavirus: a preliminary report of two casesAntivir Ther20152087–9124831606 5LaiSTTreatment"/>
 <result pre="a preliminary report of two casesAntivir Ther20152087–9124831606 5LaiSTTreatment of severe" exact="acute" post="respiratory syndromeEur J Clin Microbiol Infect Dis200524583–9116172857 6LimJJeonSShinHYKimMJSeongYMLeeWJet al.Case"/>
 <result pre="preliminary report of two casesAntivir Ther20152087–9124831606 5LaiSTTreatment of severe acute" exact="respiratory" post="syndromeEur J Clin Microbiol Infect Dis200524583–9116172857 6LimJJeonSShinHYKimMJSeongYMLeeWJet al.Case of"/>
 <result pre="of the index patient who caused tertiary transmission of COVID-19" exact="infection" post="in Korea: the application of Lopinavir/Ritonavir for the treatment"/>
 <result pre="the application of Lopinavir/Ritonavir for the treatment of COVID-19 infected" exact="pneumonia" post="monitored by quantitative RT-PCRJ Korean Med Sci2020356e7932056407 7MenacheryVDGrahamRLBaricRSJumping species-a"/>
 <result pre="of flavonoids present in aerial parts of Marcetia taxifolia against" exact="Hepatitis" post="B virus, Poliovirus, and Herpes Simplex Virus in vitroEXCLI"/>
 <result pre="for the treatment of coronavirus infectionsCurr Opin Virol201935576231125806 12Sánchez-LinaresIPérez-SánchezHCeciliaJMGarcíaJMHigh-throughput parallel" exact="blind" post="virtual screening using BINDSURFBMC Bioinformatics201213Suppl 14S13 13SavarinoAExpanding the frontiers"/>
 <result pre="Discovery Studio Visualizer by using the coordinates obtained from the" exact="Protein" post="Data Bank. Structure for A) Bat-CoV (2YNB), B) SARS-CoV"/>
 <result pre="on SARS-CoV-2 main protease. The molecular docking output represented as" exact="lower" post="binding energy frame is shown for each inhibitor. 3D"/>
</results>
